Laurie Bernstein

Prof. Laurie Bernstein


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
APAlex Pinto
Alex Pinto
MAMajid Alfadhel
Majid Alfadhel
RAR. Akroyd
R. Akroyd
YAyasemin atik altinok
yasemin atik altinok
SBS. M. Bernabei
S. M. Bernabei
Anita MacDonaldAnita MacDonald
Anita MacDonald
In fructose 1,6 bisphosphatase (FBPase) deficiency, management aims to prevent hypoglycaemia and lactic acidosis by avoiding prolonged fasting, particularly during febrile illness. Although the need for an emergency regimen to avoid metabolic decompensation is well established at times of illness, there is uncertainty about the need for other dietary management strategies such as sucrose or fructose restriction. We assessed international differences in the dietary management of FBPase deficiency. A cross-sectional questionnaire (13 questions) was emailed to all members of the Society for the Study of Inborn Errors of Metabolism (SSIEM) and a wide database of inherited metabolic disorder dietitians. Thirty-six centres reported the dietary prescriptions of 126 patients with FBPase deficiency. Patients’ age at questionnaire completion was: 1-10y, 46% (n = 58), 11-16y, 21% (n = 27), and >16y, 33% (n = 41). Diagnostic age was: 16y, 2% (n = 2). Seventy-five per cent of centres advocated dietary restrictions. This included restriction of: high sucrose foods only (n = 7 centres, 19%); fruit and sugary foods (n = 4, 11%); fruit, vegetables and sugary foods (n = 13, 36%). Twenty-five per cent of centres (n = 9), advised no dietary restrictions when patients were well. A higher percentage of patients aged >16y rather than ≤16y were prescribed dietary restrictions: patients aged 1-10y, 67% (n = 39/58), 11-16y, 63% (n = 17/27) and >16y, 85% (n = 35/41). Patients classified as having a normal fasting tolerance increased with age from 30% in 1-10y, to 36% in 11-16y, and 58% in >16y, but it was unclear if fasting tolerance was biochemically proven. Twenty centres (56%) routinely prescribed uncooked cornstarch (UCCS) to limit overnight fasting in 47 patients regardless of their actual fasting tolerance (37%). All centres advocated an emergency regimen mainly based on glucose polymer for illness management. Although all patients were prescribed an emergency regimen for illness, use of sucrose and fructose restricted diets with UCCS supplementation varied widely. Restrictions did not relax with age. International guidelines are necessary to help direct future dietary management of FBPase deficiency.

23 April 2013 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Closed access
PDF file
LBLaurie Bernstein
Laurie Bernstein
JHJ. R. Helm
J. R. Helm
Júlio César RochaJúlio César Rocha
Júlio César Rocha
Manuela Ferreira de AlmeidaManuela Ferreira de Almeida
Manuela Ferreira de Almeida
FFF. Feillet
F. Feillet
Maria GiżewskaMaria Giżewska
Maria Giżewska

16 October 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
LBLaurie Bernstein
Laurie Bernstein
Curtis CoughlinCurtis Coughlin
Curtis Coughlin
MDMorgan Drumm
Morgan Drumm
SYSTEVEN YANNICELLI
STEVEN YANNICELLI
LBLaurie Bernstein
Laurie Bernstein
Glutaric aciduria type 1 (GA-1) is a cerebral organic aciduria characterized by striatal injury and progressive movement disorder. Nutrition management shifted from a general restriction of intact protein to targeted restriction of lysine and tryptophan. Recent guidelines advocate for a low-lysine diet using lysine-free, tryptophan-reduced medical foods. GA-1 guideline recommendations for dietary management of patients over the age of six are unclear, ranging from avoiding excessive intake of intact protein to counting milligrams of lysine intake. A 22–question survey on the nutrition management of GA-1 was developed with the goal of understanding approaches to diet management for patients identified by newborn screening under age six years compared to management after diet liberalization, as well as to gain insight into how clinicians define diet liberalization. Seventy-six responses (25% of possible responses) to the survey were received. Nutrition management with GA-1 is divergent among surveyed clinicians. There was congruency among survey responses to the guidelines, but there is still uncertainty about how to counsel patients on diet optimization and when diet liberalization should occur. Ongoing clinical research and better understanding of the natural history of this disease will help establish stronger recommendations from which clinicians can best counsel families.

13 February 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
LBLaurie Bernstein
Laurie Bernstein
CBCasey Burns
Casey Burns
MDMorgan Drumm
Morgan Drumm
SGSommer Gaughan
Sommer Gaughan
MSMelissa Sailer
Melissa Sailer
Peter R. BakerPeter R. Baker
Peter R. Baker
Background: Methylmalonic acidemia (MMA) is an autosomal recessive disorder treated with precursor-free medical food while limiting natural protein. This retrospective chart review was to determine if there was a relationship between medical food, valine (VAL) and/or isoleucine (ILE) supplementation, total protein intake, and plasma amino acid profiles. Methods: A chart review, of patients aged 31 days or older with MMA treated with dietary intervention and supplementation of VAL and/or ILE and followed at the Children’s Hospital Colorado Inherited Metabolic Diseases Clinic. Dietary prescriptions and plasma amino acid concentrations were obtained at multiple time points. Results: Baseline mean total protein intake for five patients was 198% of Recommended Dietary Allowance (RDA) with 107% natural protein and 91% medical food. Following intervention, total protein intake (p = 0.0357), protein from medical food (p = 0.0142), and leucine (LEU) from medical food (p = 0.0276) were lower, with no significant change in natural protein intake (p = 0.2036). At baseline, 80% of patients received VAL supplementation and 100% received ILE supplementation. After intervention, only one of the cohort remained on supplementation. There was no statistically significant difference in plasma propiogenic amino acid concentrations. Conclusions: Decreased intake of LEU from medical food allowed for discontinuation of amino acid supplementation, while meeting the RDA for protein.

1 January 2015
Verified
Book Chapter
Closed access
PDF file
LBLaurie Bernstein
Laurie Bernstein

1 January 2015
Verified
Book Chapter
Closed access
PDF file
LBLaurie Bernstein
Laurie Bernstein
JHJoanna R. Helm
Joanna R. Helm